The global automated external defibrillator market size is estimated to reach USD 2.66 billion by 2030, and is anticipated to grow at a CAGR of 9.8% from 2024 to 2030 according to a new report by Grand View Research, Inc. The major key drivers accelerating market growth include the increasing installation of automated external defibrillators (AEDs) in public spaces, rising heart diseases due to genetic factors, aging, poor lifestyle, and technological advancements.
The emergence of cardiac diseases is very high worldwide, leading to escalated demand for the external defibrillator market. According to 2024 British Heart Foundation statistical data, around 620 million people are suffering from heart and circulatory diseases worldwide. The rising geriatric population, poor lifestyle habits, and genetic factors are likely to increase emergency cases of cardiac conditions, which in turn results in hospital admissions. The surge in hospital admissions to ICUs and emergency sectors shows the necessity for AEDs, thereby contributing to overall market growth.
Moreover, government authorities are majorly focusing on the installation of AEDs in public spaces to ensure basic cardiac support in emergency cases. For instance, in May 2022, the Delhi Government installed AEDs in crowded public places such as bus stations, railway stations, and supermarkets. This initiative aimed to provide help to cardiac patients during medical emergencies.
The introduction of technological innovations in defibrillators is driving the market growth. AEDs have been upgraded with numerous new features, such as LCD screens, rechargeable batteries, voice prompts, and new types of shocks. As a result several key market players are also focusing on technological advancement in AED devices to increase accessibility and utility to consumers. Furthermore, several companies aim to advance the technology in these devices to provide security and privacy to consumers. For instance, in January 2023, Avive Solutions, Inc. received U.S. FDA premarket approval for its device, Avive AED. The device features cellular, WiFi, GPS, and Bluetooth connectivity.
Request a free sample copy or view report summary: Automated External Defibrillator Market Report
Based on the product, semi-automated external defibrillators dominated the market with a share of 25.6% in 2023 owing to the high production of innovative and efficient AEDs by manufacturers, availability of devices, and easy usage.
Based on end-use, the hospital segment held the largest share of more than 26.01% in 2023 owing to a high number of hospital admissions due to cardiac conditions, growing installations in hospitals, and strategies implemented by key manufacturers
Based on region, North America dominated the market with a revenue share of more than 42.93% in 2023 due to the presence of leading manufacturing players, supportive regulatory approvals, and increased public access can be attributed to the growth of this region
Key players are constantly adopting several strategies to sustain their position in the market. This includes mergers and acquisitions, geographic expansion, and the launch of new products to grow in the market.
Grand View Research has segmented the global automated external defibrillator market based on product, end-use, and region:
AED Product Outlook (Revenue, USD Million, 2018 - 2030)
Fully-automated
Semi-automated
AED End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital
Pre Hospital
Public Access Market
Alternate Care Market
Home Healthcare
AED Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Automated External Defibrillator (AED) Market
Nihon Kohden Corporation
Koninklijke Philips N.V.
Progetti S.r.l.
MS Westfalia GmbH
AMI Italia S.r.l.
Silverline Meditech Pvt. Ltd.
CU Medical Systems, Inc.
Corpuls
BPL Medical Technologies
Corpuls
Physio-Control
HeartSine
Cardiac Science
Defibtech
Philips
"The quality of research they have done for us has been excellent..."